news of Alem's improvement is very welcome indeed.
very much so.
news of Alem's improvement is very welcome indeed.
Very well said. My early experiences relapsing and remitting and returning each time to as much work and exercise as I could are in total agreement with this. When healthy, we naturally increase our activities and fill our lives.[…] I am still bedbound now, still unable to talk, or listen to music, or watch TV. But I will do more when able to, this is a natural instinct or process and needs no intrusive input from others. It happens whenever people get over a cold or flu, I doubt there are tens of millions of people getting stuck in a vicious self-perpetuating cycle of symptoms, fear avoidance, deconditioning, and symptom focusing. It just goes against human nature […]
$28 million for research into Post-Acute Sequelae of COVID-19
Applications are open for the 2024 Post-Acute Sequelae of COVID-19 grant opportunity. Funding is from the Medical Research Future Fund (MRFF).
We are very pleased to share that Dr Christopher Armstrong and his team at Open Medicine Foundation's (OMF's) Melbourne ME/CFS Collaboration have been awarded nearly $1 million ($999,977.50) through the Medical Research Future Fund (MRFF) Post-Acute Sequelae of COVID-19 (PASC) Stream 1 grant, for the project Energy inefficiency in Long COVID and ME/CFS.
Importantly, this funding is a direct response to the Australian Government’s Long COVID Inquiry, Sick and tired: casting a long shadow. While the inquiry committed $50 million to Long COVID research, Recommendation 8 specifically called for dedicated investment in ME/CFS research, which has historically received limited Australian government funding despite now affecting an estimated 930,000 Australians.